On Thursday, the FDA issued its first warning to manufacturers of nicotine gum, citing the growing risks of illegal nicotine candy to young people.
The FDA has announced that flavored nicotine gum produced by VPR Brands in Florida could potentially cause nicotine poisoning and even death if consumed by young children. The regulatory agency also cited recent studies showing that nicotine candy and similar products are becoming increasingly popular among high school students.
In a statement, FDA Commissioner Robert Califf stated that "nicotine gum is a public health crisis waiting to happen among young people in our country, especially as we approach the new school year." In March, Congress passed a law granting the FDA regulatory power over all forms of nicotine, whether from tobacco companies or manufactured in laboratories. This closed a loophole in FDA oversight that previously only included nicotine from plant extracts.
VPR Brands, a manufacturer, has redesigned its square gummies to be a "smoke-free nicotine" product. In recent years, many e-cigarette companies have also claimed to have switched to synthetic nicotine.
After attempting to reach an employee of VPR Brands via telephone, no comment was given. The company has been given 15 days to remove or address their non-compliant actions following a warning letter from the FDA. VPR Brands has not yet applied for permission to sell nicotine gum. While the warning letter is not legally binding, if the company fails to comply, legal action may be taken by the FDA.
For years, the FDA has been working to reverse the trend of increasing usage of electronic cigarettes among American youth, with mixed results. Last month, the agency announced plans to ban the use of Juul e-cigarettes, but faced legal resistance from the popular e-cigarette company, resulting in the ban being postponed.
A recent study funded by the FDA has found that nicotine candy is the second most commonly used tobacco product among high school students in Southern California, second only to e-cigarettes. The FDA has issued its first warning to manufacturers of nicotine gum on Thursday.
Statement
This article is compiled from third-party information and is intended for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of the content. The translation of this article is only intended for industry communication and research.
Due to limitations in translation quality, the compiled article may differ in expression from the original text. Please refer to the original text for accuracy.
2FIRSTS fully aligns with the Chinese government's positions and statements regarding domestic, Hong Kong, Macao, Taiwan, and international issues.
The compilation of information is owned by the original media and its authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
